Tesamorelin

For Research Use Only

Injectable

A growth-hormone-releasing hormone (GHRH) analog with real regulatory standing — tesamorelin is FDA-approved for reducing excess visceral abdominal fat in a specific medical population. It works by stimulating the pituitary to release growth hormone in its natural rhythm, which signals the liver to produce IGF-1 and drives fat metabolism, with a notable preference for deep visceral fat tissue over fat just under the skin. It's one of the few peptides on this menu with a direct FDA approval behind its mechanism. Commonly used for: reducing stubborn visceral (deep abdominal) fat

This product is not for human or animal consumption. Misuse of this product is illegal.